Syngene's High Potent API Manufacturing facility скачать в хорошем качестве

Syngene's High Potent API Manufacturing facility

Ensuring the safety, containment, analysis and production of potent compounds at every stage, from development to commercialization This facility has been meticulously designed to adeptly handle cytotoxic and cytostatic high-potency compounds, demonstrating a commitment to safety with an occupational exposure limit (OEL) of up to 0.01 µg/m, over an 8-hour period, categorizing it within Band 4/5. Operating under current Good Manufacturing Practices (cGMP), the facility is positioned to meet the stringent requirements of the regulated market. Additionally, it boasts an integrated cGMP facility dedicated to the production of non-potent compounds. To further augment its capacity and capabilities, the facility is equipped with the flexibility to incorporate additional reactors and corresponding downstream equipment. The designed batch capacity stands at an impressive 30 kg, underlining the facility's efficiency and scalability in accommodating the production demands of potent pharmaceutical compounds. -For more information, contact us at [email protected] -Visit us at www.syngeneintl.com